<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04699279</url>
  </required_header>
  <id_info>
    <org_study_id>5A-Plan I</org_study_id>
    <nct_id>NCT04699279</nct_id>
  </id_info>
  <brief_title>Additive Anti-inflammatory Action for Aortopathy &amp; Arteriopathy (Rosuvastatin) I</brief_title>
  <official_title>Rosuvastatin for Primary Prevention in Acute Aortic Syndrome/Aortic Aneurysm Patients With Low to Average Low-density Lipoprotein Cholesterol Level</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Beijing Anzhen Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Nanjing Medical University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute Aortic Syndrome (AAS)/Aortic Aneurysm is a common feature of aortic wall events,&#xD;
      including aortic dissection, intramural hematoma, aortic ulceration and aortic trauma, and&#xD;
      occurs in up to 35 cases per 100,000 cases per year between the ages of 65 and 75 years.&#xD;
      Increased levels of the inflammatory biomarker high-sensitivity C-reactive protein predict&#xD;
      cardiovascular events. Since statins lower levels of high-sensitivity C-reactive protein as&#xD;
      well as cholesterol, the authors hypothesized that people with acute aortic syndrome but&#xD;
      without hyperlipidemia might benefit from statin treatment.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Aortic adverse events</measure>
    <time_frame>3 months after surgery</time_frame>
    <description>a composite outcomes event of aortic rupture, aortic dissection, severe dilation of the aorta, and cardiac death.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>3 months after surgery</time_frame>
    <description>Death from any cause</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Acute Aortic Syndrome</condition>
  <condition>Aortopathy</condition>
  <arm_group>
    <arm_group_label>Statin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Blank</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rosuvastatin 10mg</intervention_name>
    <description>Rosuvastatin 10mg is taken by oral or nasal feeding every day at ang time.</description>
    <arm_group_label>Statin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  (1) Patients with aortic dissection/ulceration/intermural hematoma/aortic aneurysm who&#xD;
             underwent aortic arch replacement or endoluminal isolation or hybrid therapy;&#xD;
&#xD;
          -  (2) Paitents without clinically significant hyperlipidemia but with cardiovascular&#xD;
             disease risk factors (such as male ≥45 years old, female ≥55 years old, hypertension,&#xD;
             diabetes, chronic kidney disease, obesity, low HDL cholesterol, smoking, alcohol&#xD;
             consumption, family history of early onset ischemic cardiovascular disease) and no&#xD;
             previous use of statins;&#xD;
&#xD;
          -  (3) Patients are between 18 and 85 years old, male or female;&#xD;
&#xD;
          -  (4) Agree to participate in the study and sign the informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  (1) Patients with allergy to statins;&#xD;
&#xD;
          -  (2) patients with active liver disease;&#xD;
&#xD;
          -  (3) patients with myopathy;&#xD;
&#xD;
          -  (4) Lactating women and pregnant women;&#xD;
&#xD;
          -  (5) Patients with mental diseases, drug and alcohol dependence;&#xD;
&#xD;
          -  (6) Refuse to participate in the study or sign the informed consent.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hong Liu, MD</last_name>
    <phone>18801281613</phone>
    <email>DR.HONGLIU@FOXMAIL.COM</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yong-feng SHAO, MD</last_name>
    <phone>18801281613</phone>
    <email>YFSHAOJPH@SINA.COM</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The first affiliated hospital of nanjing medical university</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210029</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hong Liu, MD</last_name>
      <phone>188012181613</phone>
      <email>dr.hongliu@foxmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Beijing Anzhen Hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Si-chong Qian, MD</last_name>
      <phone>13120130755</phone>
      <email>drqsc1990a@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>January 6, 2021</study_first_submitted>
  <study_first_submitted_qc>January 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 7, 2021</study_first_posted>
  <last_update_submitted>July 23, 2021</last_update_submitted>
  <last_update_submitted_qc>July 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nanjing Medical University</investigator_affiliation>
    <investigator_full_name>Hong Liu</investigator_full_name>
    <investigator_title>Principal Investigator of Cardiovascular surgery Dept.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rosuvastatin Calcium</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

